Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On July 30, 2024, PepGen released data from its ongoing Phase 2 trial of its drug candidate PGN-EDO51. On this news, PepGen stock fell over 45% during intraday trading on July 31, 2024.
Ticker Symbol | Company Name | Join Deadline | |
---|---|---|---|
NSSC | Napco Security Technologies, Inc. | June 24, 2025 | Join |
NSSC | Napco Security Technologies, Inc. | June 24, 2025 | Join |
NSSC | Napco Security Technologies, Inc. | June 24, 2025 | Join |
CODI | Compass Group Diversified Holdings, LLC | July 08, 2025 | Join |
IOVA | Iovance Biotherapeutics, Inc. | July 14, 2025 | Join |